Novel multilayer tube design enables infusion of drug products suspended in DMSO
How TekniPlex Healthcare developed a tubing solution that both solved the problem and saved money
June 5, 2024
Revolutionizing Dual Hormone Infusion Systems for Enhanced Patient Care
Developing a dual hormone infusion system for insulin and DMSO-suspended glucagon faced significant hurdles. Existing multilayer tubing products failed due to DMSO's corrosive effects, risking both market viability and patient safety from potential hypoglycemia. TekniPlex Healthcare created a patented infusion system that eliminates UV curable adhesives, lowering costs and simplifying manufacturing. Key features include continuous fluid transfer, easy manufacturing, and strong tube-to-fitting bonds.
Other Articles
Styrenic TPE Compounds: Growth Drivers & Challenges in Medical Applications
June 5, 2024
TekniPlex Healthcare helps companies commercialize swab sticks for COVID-19 testing needs
June 5, 2024
TekniPlex Healthcare coextruded barrier structures enable commercialization of emerging drug therapies
June 5, 2024